Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression

Posted by: | November 11, 2019 | Comments

Gut dysbiosis and immune cell changes during disease progression in 5XFAD transgenic (Tg) mice, specifically changes in CD45 cells in 5XFAD transgenic (Tg) mice at different time points (n = 4–8). On the barplot, cell counts are presented relative to the frequency of CD45 cells. Colours indicate different subtypes of CD45 cells: Neu, neutrophils; DC, dendritic cells; NK, natural killer cells; Mo/Mϕ ː monocytes and macrophages; B, B cells; Others, unclassified cells.


Recently, increasing evidence has suggested the association between gut dysbiosis and Alzheimer’s disease (AD) progression, yet the role of gut microbiota in AD pathogenesis remains obscure. Herein, we provide a potential mechanistic link between gut microbiota dysbiosis and neuroinflammation in AD progression. Using AD mouse models, we discovered that, during AD progression, the alteration of gut microbiota composition leads to the peripheral accumulation of phenylalanine and isoleucine, which stimulates the differentiation and proliferation of pro-inflammatory T helper 1 (Th1) cells. The brain-infiltrated peripheral Th1 immune cells are associated with the M1 microglia activation, contributing to AD-associated neuroinflammation. Importantly, the elevation of phenylalanine and isoleucine concentrations and the increase of Th1 cell frequency in the blood were also observed in two small independent cohorts of patients with mild cognitive impairment (MCI) due to AD. Furthermore, GV-971, a sodium oligomannate that has demonstrated solid and consistent cognition improvement in a phase 3 clinical trial in China, suppresses gut dysbiosis and the associated phenylalanine/isoleucine accumulation, harnesses neuroinflammation and reverses the cognition impairment.

Read more at: Cell Research

Xinyi Wang, Guangqiang Sun, Teng Feng, Jing Zhang, Xun Huang, Tao Wang, Zuoquan Xie, Xingkun Chu, Jun Yang, Huan Wang, Shuaishuai Chang, Yanxue Gong, Lingfei Ruan, Guanqun Zhang, Siyuan Yan, Wen Lian, Chen Du, Dabing Yang, Qingli Zhang, Feifei Lin, Jia Liu, Haiyan Zhang, Changrong Ge, Shifu Xiao, Jian Ding & Meiyu Geng. Cell Research. DOI: 06 Sept 2019.

Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required
Privacy Policy

Terms & Conditions | Privacy Policy | © 2020 The Translational Microbiome Research Forum